RENATA Stock Overview
Manufactures, markets, and distributes human pharmaceuticals, animal health medicines, nutritionals, and vaccines in Bangladesh. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
Renata PLC Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ৳640.10 |
| 52 Week High | ৳1,217.90 |
| 52 Week Low | ৳608.30 |
| Beta | 0.045 |
| 11 Month Change | -6.35% |
| 3 Month Change | -16.09% |
| 1 Year Change | -47.44% |
| 33 Year Change | -47.51% |
| 5 Year Change | -28.88% |
| Change since IPO | 21,864.58% |
Recent News & Updates
Recent updates
Shareholder Returns
| RENATA | BD Pharmaceuticals | BD Market | |
|---|---|---|---|
| 7D | -2.5% | -2.3% | -0.9% |
| 1Y | -47.4% | -25.3% | -20.0% |
Return vs Industry: RENATA underperformed the BD Pharmaceuticals industry which returned -25.3% over the past year.
Return vs Market: RENATA underperformed the BD Market which returned -20% over the past year.
Price Volatility
| RENATA volatility | |
|---|---|
| RENATA Average Weekly Movement | 3.9% |
| Pharmaceuticals Industry Average Movement | 8.3% |
| Market Average Movement | 7.0% |
| 10% most volatile stocks in BD Market | 9.3% |
| 10% least volatile stocks in BD Market | 3.9% |
Stable Share Price: RENATA has not had significant price volatility in the past 3 months compared to the BD market.
Volatility Over Time: RENATA's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1972 | 7,119 | Syed S. Kabir | www.renata-ltd.com |
Renata PLC manufactures, markets, and distributes human pharmaceuticals, animal health medicines, nutritionals, and vaccines in Bangladesh. Its pharmaceutical products include antimicrobials, anti-hypertensive, anti-angina, anti-diabetic, eye-ear and topical preparation, antigout, NSAID, anti-spasmodic, steroid, anti-osteoporotic, anti-allergic, cardiovascular, CNS, hormone, anti-cancer, oxytocic, anti-fibrinolytic, anti-asthma, expectorant, oral rehydration saline, narcotic analgesic, antipyretic/analgesic, antiemetic, anesthetic, antiviral, and other products. The company also offers lipid lowering, antiulcer, anti-parasitic and anti-protozoal, anti-fungal, anti-tuberculosis, and gastroprokinetic agents; and vitamins and minerals.
Renata PLC Fundamentals Summary
| RENATA fundamental statistics | |
|---|---|
| Market cap | ৳73.42b |
| Earnings (TTM) | ৳3.62b |
| Revenue (TTM) | ৳37.71b |
20.3x
P/E Ratio1.9x
P/S RatioIs RENATA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RENATA income statement (TTM) | |
|---|---|
| Revenue | ৳37.71b |
| Cost of Revenue | ৳21.03b |
| Gross Profit | ৳16.68b |
| Other Expenses | ৳13.06b |
| Earnings | ৳3.62b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 31.53 |
| Gross Margin | 44.23% |
| Net Profit Margin | 9.59% |
| Debt/Equity Ratio | 51.6% |
How did RENATA perform over the long term?
See historical performance and comparisonDividends
1.4%
Current Dividend Yield31%
Payout RatioDoes RENATA pay a reliable dividends?
See RENATA dividend history and benchmarks| Renata dividend dates | |
|---|---|
| Ex Dividend Date | Oct 22 2024 |
| Dividend Pay Date | Jan 05 2025 |
| Days until Ex dividend | 31 days |
| Days until Dividend pay date | 44 days |
Does RENATA pay a reliable dividends?
See RENATA dividend history and benchmarks